You can help in the effort against HIV
Education and treatment alone won't end the HIV epidemic. The world needs a vaccine against HIV. The CFA supports the search, through well-designed clinical trials, for a safe and effective HIV vaccine, and we recognize the importance of public support in finding a vaccine. In collaboration with the Baylor College of Medicine and the HIV Vaccine Trials Network, The CFA is now identifying potential volunteers for a study of one type of vaccine.
The vaccine under study is not expected to prevent HIV infection; rather, the hope is that the vaccine will lower viral load and delay the onset of illness in individuals who become infected with HIV. The vaccine under study cannot cause HIV infection. The results from this study will be used to improve future vaccine research.
For reasons explained here, volunteers for this study must be 1) U.S. males or transgender women who have sex men, 2) circumcised, 3) not younger than 18 and not older than 45, and 4) negative for antibodies to both HIV and adenovirus type 5. Other important criteria apply.
If you'd like to volunteer for the study, or if you just want to learn more, call 713.527.8219.